Secarna Pharmaceuticals: Data published in Molecular Diagnostics & Therapy demonstrate how Secarna’s powerful bioinformatics generate improved LNA-modified antisense oligonucleotide therapies

Written by Petra Hegmann on 20th January 2021. Posted in Client News.